68 related articles for article (PubMed ID: 8162601)
1. Extracts of porcine pancreas prevent progression of hypercalcemia and cachexia and prolong survival in nude mice bearing a human squamous carcinoma.
Yoneda T; Takaoka Y; Boyce BF; Scott L; Mundy GR
Cancer Res; 1994 May; 54(9):2509-13. PubMed ID: 8162601
[TBL] [Abstract][Full Text] [Related]
2. Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer.
Yoneda T; Williams P; Rhine C; Boyce BF; Dunstan C; Mundy GR
Cancer Res; 1995 May; 55(9):1989-93. PubMed ID: 7728770
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
[TBL] [Abstract][Full Text] [Related]
4. Dependence of a human squamous carcinoma and associated paraneoplastic syndromes on the epidermal growth factor receptor pathway in nude mice.
Yoneda T; Alsina MM; Watatani K; Bellot F; Schlessinger J; Mundy GR
Cancer Res; 1991 May; 51(9):2438-43. PubMed ID: 2015605
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of hypercalcemia and leukocytosis with cachexia in a human squamous cell carcinoma of the maxilla in athymic nude mice: a novel experimental model of three concomitant paraneoplastic syndromes.
Yoneda T; Aufdemorte TB; Nishimura R; Nishikawa N; Sakuda M; Alsina MM; Chavez JB; Mundy GR
J Clin Oncol; 1991 Mar; 9(3):468-77. PubMed ID: 1999718
[TBL] [Abstract][Full Text] [Related]
7. Prolonged decrease of serum calcium concentration by murine gamma-interferon in hypercalcemic, human tumor (EC-GI)-bearing nude mice.
Sato K; Satoh T; Shizume K; Yamakawa Y; Ono Y; Demura H; Akatsu T; Takahashi N; Suda T
Cancer Res; 1992 Jan; 52(2):444-9. PubMed ID: 1728416
[TBL] [Abstract][Full Text] [Related]
8. Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice.
Yoneda T; Alsina MA; Chavez JB; Bonewald L; Nishimura R; Mundy GR
J Clin Invest; 1991 Mar; 87(3):977-85. PubMed ID: 1999505
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing antibodies to human interleukin 6 reverse hypercalcemia associated with a human squamous carcinoma.
Yoneda T; Nakai M; Moriyama K; Scott L; Ida N; Kunitomo T; Mundy GR
Cancer Res; 1993 Feb; 53(4):737-40. PubMed ID: 8428354
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor progression and paraneoplastic syndrome development in a murine lung adenocarcinoma by medroxyprogesterone acetate and indomethacin.
Diament MJ; Peluffo GD; Stillitani I; Cerchietti LC; Navigante A; Ranuncolo SM; Klein SM
Cancer Invest; 2006 Mar; 24(2):126-31. PubMed ID: 16537180
[TBL] [Abstract][Full Text] [Related]
11. Expression of human transforming growth factor alpha by Chinese hamster ovarian tumors in nude mice causes hypercalcemia and increased osteoclastic bone resorption.
Yates AJ; Boyce BF; Favarato G; Aufdemorte TB; Marcelli C; Kester MB; Walker R; Langton BC; Bonewald LF; Mundy GR
J Bone Miner Res; 1992 Jul; 7(7):847-53. PubMed ID: 1642153
[TBL] [Abstract][Full Text] [Related]
12. Effect of combination treatment with a vitamin D analog (OCT) and a bisphosphonate (AHPrBP) in a nude mouse model of cancer-associated hypercalcemia.
Endo K; Katsumata K; Iguchi H; Kubodera N; Teramoto T; Ikeda K; Fujita T; Ogata E
J Bone Miner Res; 1998 Sep; 13(9):1378-83. PubMed ID: 9738509
[TBL] [Abstract][Full Text] [Related]
13. Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy.
Capparelli C; Kostenuik PJ; Morony S; Starnes C; Weimann B; Van G; Scully S; Qi M; Lacey DL; Dunstan CR
Cancer Res; 2000 Feb; 60(4):783-7. PubMed ID: 10706080
[TBL] [Abstract][Full Text] [Related]
14. Porcine pancreas extract decreases blood-ionized calcium in mice and inhibits osteoclast formation and bone resorption in culture.
Yoneda T; Takaoka Y; Alsina MM; Garcia J; Mundy GR
FEBS Lett; 1991 Jan; 278(2):171-4. PubMed ID: 1991507
[TBL] [Abstract][Full Text] [Related]
15. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
16. Association of hypercalcemia with tumors producing colony-stimulating factor(s).
Kondo Y; Sato K; Ohkawa H; Ueyama Y; Okabe T; Sato N; Asano S; Mori M; Ohsawa N; Kosaka K
Cancer Res; 1983 May; 43(5):2368-74. PubMed ID: 6600966
[TBL] [Abstract][Full Text] [Related]
17. Increased renal calcium reabsorption in an animal model of hypercalcemia of human malignancy.
Shipley PJ; Shevrin DH; Kukreja SC
J Bone Miner Res; 1988 Oct; 3(5):555-60. PubMed ID: 3195367
[TBL] [Abstract][Full Text] [Related]
18. Clodronate alleviates cachexia and prolongs survival in nude mice xenografted with an anaplastic thyroid carcinoma cell line.
Wang CH; Shen YC; Hsieh JJ; Yeh KY; Chang JW
J Endocrinol; 2006 Aug; 190(2):415-23. PubMed ID: 16899574
[TBL] [Abstract][Full Text] [Related]
19. Peripheral administration of a melanocortin 4-receptor inverse agonist prevents loss of lean body mass in tumor-bearing mice.
Nicholson JR; Kohler G; Schaerer F; Senn C; Weyermann P; Hofbauer KG
J Pharmacol Exp Ther; 2006 May; 317(2):771-7. PubMed ID: 16436498
[TBL] [Abstract][Full Text] [Related]
20. Bone resorption and renal calcium reabsorption in renal cell carcinoma-bearing mice: the effects of bisphosphonate.
Weissglas M; Löwik C; Schamhart D; Theuns H; Kurth KH; Papapoulos S
BJU Int; 2007 Jun; 99(6):1530-3. PubMed ID: 17428243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
